Satsuma Pharmaceuticals Statistics Share Statistics Satsuma Pharmaceuticals has 33.15M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 33.15M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 15.2M Failed to Deliver (FTD) Shares 238 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 56.61K, so 0% of the outstanding
shares have been sold short.
Short Interest 56.61K Short % of Shares Out n/a Short % of Float 0.2% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.42 and the forward
PE ratio is null.
Satsuma Pharmaceuticals's PEG ratio is
-0.02.
PE Ratio -0.42 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -0.14 P/FCF Ratio -0.55 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Satsuma Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.75,
with a Debt / Equity ratio of 0.
Current Ratio 6.75 Quick Ratio 6.75 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -5457.46
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.77M Employee Count 25 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -892K Effective Tax Rate 1.27%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.1, so Satsuma Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.1 52-Week Price Change n/a 50-Day Moving Average 0.97 200-Day Moving Average 2.38 Relative Strength Index (RSI) 60.82 Average Volume (20 Days) 1,106,610
Income Statement
Revenue n/a Gross Profit n/a Operating Income -70.95M Net Income -69.16M EBITDA -58.31M EBIT -70.04M Earnings Per Share (EPS) -2.16
Full Income Statement Balance Sheet The company has 16.43M in cash and 138K in
debt, giving a net cash position of 16.29M.
Cash & Cash Equivalents 16.43M Total Debt 138K Net Cash 16.29M Retained Earnings -211.79M Total Assets 43.48M Working Capital 37.54M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -51.52M
and capital expenditures -472K, giving a free cash flow of -51.99M.
Operating Cash Flow -51.52M Capital Expenditures -472K Free Cash Flow -51.99M FCF Per Share -1.62
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
